Alembic Pharmaceuticals Secures USFDA Approval for Generic Paroxetine Extended-Release Tablets
Approval Strengthens Alembic’s US Generics Portfolio
New Delhi, March 30: Alembic Pharmaceuticals Ltd on Monday announced that it has received final approval from the United States Food and Drug...
India’s Pharmaceutical Industry Strengthens Global Position, Eyes $130 Billion Market by 2030
Sector Ranks Third Globally by Volume with Expanding Manufacturing Base
New Delhi, March 21: India’s pharmaceutical industry continues to solidify its position as a globally integrated and...
Lupin Receives USFDA Nod for Seizure Treatment Drug
Mumbai based pharmaceutical major Lupin Ltd on Wednesday announced that it has received approval from the U.S. Food and Drug Administration to market a generic medication used in the treatment of seizures in the United States.The approval...
anda
brivaracetam
briviact
bse
drug approval
generic medication
india
lupin
oral solution
pharmaceutical industry
pharmaceutical sales
seizures
us market
usfda